51 results on '"Lohse, Ansgar"'
Search Results
2. Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy
3. Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) – a multicenter, randomized, controlled, open-label investigator-initiated trial
4. Reply to: Challenges in interpreting the role of gentamicin in treatment of invasive listeriosis: immortal timebias and confounding
5. „Hühnerbrühe bei Durchfall ist Folklore!“
6. Autoimmune Hepatitis: Von Autoantikörpern bis Zirrhose
7. EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma
8. Muscle quality determined by computed tomography predicts short-term and long-term survival after liver transplantation
9. Improving quality of life in patients with rare autoimmune liver diseases by structured peer-delivered support (Q.RARE.LI): study protocol for a transnational effectiveness-implementation hybrid trial
10. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
11. MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis
12. Mini-laparoscopy as a diagnostic tool for abdominal tuberculosis: a retrospective series of 29 cases
13. Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy
14. Hepatische Granulome – eine diagnostische Herausforderung
15. B cells in autoimmune hepatitis: bystanders or central players?
16. Disturbed lipid and amino acid metabolisms in COVID-19 patients
17. Tolerance and autoimmunity in the liver
18. Mit Verstand und Bauchgefühl -Viszeralmedizin 2023
19. Molecular consequences of SARS-CoV-2 liver tropism
20. Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial
21. Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients
22. Schwere sekundär sklerosierende Cholangitis als Manifestation einer sehr seltenen Grunderkrankung
23. Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
24. Europäisches Referenznetzwerk für seltene Lebererkrankungen (ERN RARE-LIVER)
25. Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy
26. Diagnosis of abdominal tuberculosis by mini-laparoscopy
27. Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
28. Cardiovascular magnetic resonance demonstrates structural cardiac changes following transjugular intrahepatic portosystemic shunt
29. Extended cycle streptozotocin/5-FU chemotherapy for maintenance therapy in pancreatic neuroendocrine tumors
30. Management der saisonalen Influenza 2017/2018: Erfahrungen an einem deutschen Universitätsklinikum
31. Erratum zu: Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
32. Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype
33. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort
34. Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center
35. Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma—correlation with liver cancer and liver cirrhosis
36. Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI)
37. HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules
38. Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER
39. Autoimmune Hepatitis: When Is It Safe to Stop Therapy, or Withhold Therapy Altogether?
40. Autoimmune hepatitis
41. Diffusion-weighted MRI for detection of hepatic osteodystrophy in primary sclerosing cholangitis: a comparison study with dual-energy X-ray absorptiometry
42. Unique human immune signature of Ebola virus disease in Guinea
43. Nonalcoholic Fatty Liver Disease in Patients with Autoimmune Hepatitis: Further Reason for Teeth GNASHing?
44. Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin
45. Effectiveness and safety of minilaparoscopy-guided spleen biopsy: a retrospective series of 57 cases
46. Clostridium-difficile-assoziierte Diarrhö – ein Update
47. Altes und Neues zur antibiotikaassoziierten Diarrhö
48. Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis
49. Hepatocellular expression of a dominant-negative mutant TGF-β type II receptor accelerates chemically induced hepatocarcinogenesis
50. CASE REPORT: Progressive Focal Nodular Hyperplasia of the Liver in a Patient with Genetic Hemochromatosis–Growth Promotion by Iron Overload?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.